Description
| Method: | CMIA, CLIA |
| Comment: | |
| Price: | 3000.00 |
| Report: | Sample Mon / Thu by 11 am; Report Same day |
| Usage: | Prostate health index (PHI) combines three PSA forms (total PSA, free PSA, and p2PSA) into a single score. p2PSA test measures the proPSA concentration in serum. ProPSA is one of the isoform of free PSA which has been determined to be most specific to Prostate cancer. PHI demonstrates a significant improvement in clinical specificity for prostate cancer detection, relative to PSA alone in men 50 years of age or older with a PSA range of 2-10 ng/mL and with non-suspicious digital rectal exam (DRE) findings. At 95% clinical sensitivity, the clinical specificity for PHI is 18.2% as compared to 6.6% for free PSA in diagnostic grey zone. A low PHI result indicates lower risk of Prostate cancer, while an elevated PHI result may suggest that a prostate biopsy is necessary to rule out cancer.CA 19.9 is useful to monitor the response to treatment and if elevated suggests recurrence in patients with Pancreatic Cancer. Elevated concentrations are not specific. Use in patients with other medical conditions is not advised.HCG is a hormone produced by the syncytiotrophoblast of the placenta. HCG concentrations are increased in cases of Testicular tumors, Ovarian germ cell tumors and Gestational trophoblastic disease. Increased levels of CEA are found in patients with primary Colorectal carcinoma and other malignancies like Medullary thyroid carcinoma and Carcinoma of breast, GI tract, liver, lung, ovarian, pancreatic and prostate. Serial monitoring of CEA should begin prior to therapy to establish a baseline for evaluating possible recurrence. Levels generally return to normal within 1 to 4 months after removal of tumor. Smokers show a higher baseline level of CEA. |
| Doctor Specialty: | Oncologist |
| Disease: | Prostate Cancer |
| Components: | *PSA, Total *PSA, Free *P2PSA,CA19.9, BHCG,CEA |
| Courier Charges: | |
| Home Collection: | Available |
| Department: | THYROID & HORMONES |
| Pre Test Information: | Do not give sample within 7 days of Digital Rectal Examination (DRE) or Rectal Prostatic Ultrasonography. |
